• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ: OPRX )

4.830 -0.080 (-1.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
Today 8:45 EST
From OptimizeRx Corporation
Via GlobeNewswire
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
December 20, 2024
Via Benzinga
OptimizeRx to Participate in Upcoming Investor Conferences
November 18, 2024
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 14, 2024
Via Benzinga
Earnings Scheduled For November 13, 2024
November 13, 2024
Via Benzinga
Preview: OptimizeRx's Earnings
November 12, 2024
Via Benzinga
A Closer Look at 5 Analyst Recommendations For OptimizeRx
August 12, 2024
Via Benzinga
OptimizeRx Reports Third Quarter 2024 Financial Results
November 13, 2024
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 06, 2024
Via Benzinga
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
October 31, 2024
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
September 10, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
June 21, 2024
Via Benzinga
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
September 09, 2024
From OptimizeRx Corporation
Via GlobeNewswire
OPRX Stock Earnings: OptimizeRx Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
OptimizeRx Reports Second Quarter 2024 Financial Results
August 08, 2024
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
July 25, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Expert Ratings For OptimizeRx
May 15, 2024
Via Benzinga
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
July 23, 2024
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
July 15, 2024
The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program 
From OptimizeRx Corporation
Via GlobeNewswire
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
June 20, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results
May 15, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 15, 2024
Via Benzinga
Nasdaq Surges 150 Points; Retail Sales Flat For April
May 15, 2024
Via Benzinga
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 15, 2024
Via Benzinga
OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024
May 14, 2024
OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 14, 2024
Via Benzinga
OptimizeRx Reports First Quarter 2024 Financial Results
May 14, 2024
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
May 06, 2024
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
April 26, 2024
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024
From OptimizeRx Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap